Pharma Industry News Weekly Recap: March 24, 2023
// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label [...]
Pharma Industry News Weekly Recap: March 17, 2023
// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]
Pharma Industry News Weekly Recap: March 10, 2023
// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]
Pharma Industry News Weekly Recap: March 3, 2023
// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]
NOPAIN ACT, COVID-19, And The Opioid Crisis
While Covid-19 was ravaging our country over the past year, America was also fighting another epidemic: the ongoing battle against [...]
J.P. Morgan 38th Annual Healthcare Conference (JPM 2020)
60 days until the J.P. Morgan 38th annual Healthcare Conference (#JPM2020). Removing the upcoming holidays and weekends, we’re talking 36 [...]
79th American Diabetes Association
Diabetes, once considered a disease of the pancreas, is now understood to be a complex, multi-hormonal disease leading to devastating [...]
Jardiance Asks: Consumer Campaign
Boehringer Ingelheim & Eli Lilly and Evoke Health for Jardiance Jardiance Asks: Consumer Campaign An authentic approach successfully [...]
Teva Migraine Drug Ajovy Wins FDA Approval
Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the [...]
Abilify, Otsuka’s Dose-tracking Digital Pill Deal With Magellan
Get ready for the first “smart pill” to make its way to medicine cabinets. Otsuka’s Abilify MyCite, the only FDA-approved [...]